ALL vs ESLAW
The Allstate Corporation (ALL) versus Estrella Immunopharma Inc. (ESLAW) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Estrella Immunopharma Inc. (ESLAW) is a biotechnology company listed on US.
Latest reported ALL revenue for 2026-06-30 was $18.60B. Net income was $3.27B. Revenue was up 9.8% from 2026-03-31 to 2026-06-30. ALL currently screens at market cap $56.89B and trailing P/E 4.9.
ESLAW does not have a complete income-statement cache yet.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. ESLAW currently screens at market cap $0.
Not investment advice. Open the ALL and ESLAW stock pages for the full models.
Not investment advice.